SCHEMBL10437585

SCHEMBL10437585

O=C1CC(O)CC(/C=C/C(=C(c2ccc(F)cc2)c2ccc(F)cc2)n2cnnn2)O1

nearest known ligand 0.60

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 9/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10554642 1.00 HMGCR (0.46) HMGCR
SCHEMBL10554637 1.00 HMGCR (0.46) HMGCR
SCHEMBL10437586 1.00 HMGCR (0.46) HMGCR
SCHEMBL10552767 1.00 HMGCR (0.46) HMGCR
SCHEMBL10550364 0.81 HMGCR (0.47) HMGCR
SCHEMBL10550356 0.81 HMGCR (0.47) HMGCR
SCHEMBL10550351 0.81 HMGCR (0.47) HMGCR
SCHEMBL10550361 0.81 HMGCR (0.47) HMGCR
SCHEMBL10550373 0.81 HMGCR (0.47) HMGCR
SCHEMBL6905038 0.75 HMGCR (0.48) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0355820-A1 Antihypercholesterolemic tetrazol-1-yl compounds Bristol-Myers Squibb Company (US) 1990-02-28 EP claimed
US-4870187-A ANTILIPEMIC, ATHEROSCLEROSIS BRISTOL-MYERS COMPANY (US) 1989-09-26 US claimed